BioPharma Credit PLC (LON:BPCR)

Market Cap	791.57M +7.7%
Revenue (ttm)	117.21M +5.1%
Net Income	96.51M +6.3%
EPS	0.08 +14.0%
Shares Out	1.12B
PE Ratio	8.30
Forward PE	n/a
Dividend	0.07 (10.54%)
Ex-Dividend Date	Apr 30, 2026

Volume	684,063
Open	0.9420
Previous Close	0.9440
Day's Range	0.9400 - 0.9520
52-Week Range	0.8560 - 1.0000
Beta	0.18
Analysts	Buy
Price Target	n/a
Earnings Date	Sep 23, 2026

About BioPharma Credit

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.

• Industry: Asset Management
• Sector: Financials
• Founded: 2016
• Country: United Kingdom
• Stock Exchange: London Stock Exchange
• Ticker Symbol: BPCR

Financial Performance

In 2025, BioPharma Credit's revenue was $157.75 million, an increase of 5.14% compared to the previous year's $150.03 million. Earnings were $129.89 million, an increase of 6.31%.

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 15, 2026

Data Sources Report a data error